Your browser doesn't support javascript.
loading
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges.
Zheng, Haiqiong; Chen, Yijin; Luo, Qian; Zhang, Jie; Huang, Mengmeng; Xu, Yulin; Huo, Dawei; Shan, Wei; Tie, Ruxiu; Zhang, Meng; Qian, Pengxu; Huang, He.
Afiliación
  • Zheng H; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310012, China.
  • Chen Y; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Luo Q; Institute of Hematology, Zhejiang University, Hangzhou, 310012, China.
  • Zhang J; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, 310012, China.
  • Huang M; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310012, China.
  • Xu Y; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Huo D; Institute of Hematology, Zhejiang University, Hangzhou, 310012, China.
  • Shan W; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, 310012, China.
  • Tie R; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310012, China.
  • Zhang M; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Qian P; Institute of Hematology, Zhejiang University, Hangzhou, 310012, China.
  • Huang H; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, 310012, China.
Cell Regen ; 12(1): 31, 2023 Sep 01.
Article en En | MEDLINE | ID: mdl-37656237
Human pluripotent stem cells (hPSCs) have been suggested as a potential source for the production of blood cells for clinical application. In two decades, almost all types of blood cells can be successfully generated from hPSCs through various differentiated strategies. Meanwhile, with a deeper understanding of hematopoiesis, higher efficiency of generating progenitors and precursors of blood cells from hPSCs is achieved. However, how to generate large-scale mature functional cells from hPSCs for clinical use is still difficult. In this review, we summarized recent approaches that generated both hematopoietic stem cells and mature lineage cells from hPSCs, and remarked their efficiency and mechanisms in producing mature functional cells. We also discussed the major challenges in hPSC-derived products of blood cells and provided some potential solutions. Our review summarized efficient, simple, and defined methodologies for developing good manufacturing practice standards for hPSC-derived blood cells, which will facilitate the translation of these products into the clinic.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Cell Regen Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Cell Regen Año: 2023 Tipo del documento: Article País de afiliación: China
...